Valuation: LataMed AI Corp.

Market Cap 9M 8.04M 7.5M 6.82M 12.84M 871M 12.93M 90.17M 35.23M 443M 33.79M 33.06M 1.42B P/E 2024
-3.63x
P/E 2025 -102x
Enterprise Value 9.4M 8.4M 7.83M 7.11M 13.4M 909M 13.5M 94.12M 36.77M 462M 35.27M 34.51M 1.49B EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
96.45%
Yield 2024 *
-
Yield 2025 -
09-09 LataMed AI VE Enters Healthcare Technology Cooperation Agreement with Venezuelan Science and Health Ministries for La Guaira Deployment CI
09-09 Latamed Ai Corp. Enters Healthcare Technology Cooperation Agreement with Venezuela?s Ministry of Popular Power for Science and Technology and Ministry of Popular Power for Health for La Guaira Deployment CI
08-19 Latamed Ai Corp. Nears Completion of Mobile Healthcare Application CI
08-12 LataMed AI VE Enters Strategic Collaboration With Caracas FC to Explore AI-Powered Athletic Performance and Operational Analytics CI
08-12 LataMed AI Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
08-03 LataMed AI Corp. And DROGUERIAS LALA C.A. Enter Agreement To Develop AI And Automation Tools For Pharmaceutical And Laboratory Workflows CI
07-31 LataMed AI Corp. And Venezuelan Institute For Scientific Research Enter Agreement To Develop Digital Platform Supporting Access To IVIC Laboratory Services CI
07-28 LataMed AI Corp. Announces Through its Venezuelan Operating Subsidiary Enters Agreements with Colegio Claret and Colegio Roraima to Develop School-Based Digital Healthcare Initiatives CI
07-23 LataMed AI Corp. through its subsidiary LATAMEDAI VE, and FARMASER Enter Memorandum of Understanding to Develop Automation Platform for Pharmacy Operations CI
07-20 LataMed AI Corp Advances Industrial Telemedicine Initiative For Remote And Offshore Operations In Venezuela CI
07-06 LataMed AI Corp. Begins Planned Expansion into Colombia Through Initial Due Diligence and Strategic Planning CI
07-01 Latamed Ai Ve Executes Strategic Commercial Alliance with Cantv to Expand Digital Healthcare Services Across Venezuela CI
06-30 Latamed Ai Corp. and Vértice Seguros C.A. Execute Strategic Commercial Alliance to Expand Digital Healthcare and Insurance Ecosystem CI
1 day+65.51%
1 week-17.00%
Current month-17.00%
1 month-88.42%
3 months-93.57%
6 months-81.51%
Current year-61.70%
1 week 0.03
Extreme 0.0301
0.07
1 month 0.03
Extreme 0.0301
0.48
Current year 0.03
Extreme 0.0301
1.38
1 year 0.03
Extreme 0.0301
1.38
3 years 0.03
Extreme 0.0301
135
5 years 0.03
Extreme 0.0301
135
10 years 0.03
Extreme 0.0301
135
Manager TitleAgeSince
Chief Executive Officer 31 17/02/2026
Director of Finance/CFO 38 31/03/2026
Director TitleAgeSince
Director/Board Member 31 17/02/2026
Change 5-day change 1-year change 3-year change Capi.($)
+65.51%-17.00%-61.70%-99.71% 9M
+0.03%+1.49%+17.14%+41.76% 30.73B
+0.35%+0.65%+1.53%+29.22% 24.81B
+0.21%+4.12%+7.29%+7.07% 7.7B
-2.17%+0.22%+79.45%+87.83% 7.39B
+2.33%+3.54%+24.55%+34.18% 5.97B
+0.83%+2.55%+24.60%+92.96% 4.89B
-1.91%-1.91%+88.25%+245.11% 3.7B
-1.71%+2.16%+53.45%-20.49% 3.54B
-2.55%-2.55%-7.97%+74.17% 3.17B
Average +6.09%-2.55%+22.66%+49.21% 9.19B
Weighted average by Cap. -0.08%+0.01%+21.37%+48.29%

Financials

2024 2025
Net sales - -
Net income -3.26M -2.91M -2.72M -2.47M -4.65M -315M -4.69M -32.67M -12.76M -160M -12.24M -11.98M -516M -207K -185K -173K -157K -296K -20.07M -298K -2.08M -812K -10.21M -779K -762K -32.81M
Net Debt 339K 303K 283K 257K 484K 32.83M 488K 3.4M 1.33M 16.69M 1.27M 1.25M 53.67M 395K 353K 329K 299K 563K 38.2M 567K 3.96M 1.55M 19.43M 1.48M 1.45M 62.46M
Projected Income Statement - Annual - LataMed AI Corp.
Logo LataMed AI Corp.
LataMed AI Corp., formerly Catalyst Crew Technologies Corp. is a Venezuela-based company primarily active in the Healthcare Technology sector. The Company is digital health and artificial intelligence technology enterprise, focusing on building telehealth infrastructure, healthcare coordination tools, analytics capabilities, and AI-enabled healthcare solutions for emerging markets. Such technologies are designed d to support healthcare access, patient engagement, provider coordination, emergency medical response, pharmacy integration, insurance accessibility, payment solutions, and data-driven healthcare operations, with an initial regional focus on Latin American markets. The Company owns intellectual property assets relating to its artificial intelligence-enabled healthcare analytics platform, including issued patents and proprietary software, while the modules are in development.
Employees
3
Date Price Change Volume
07/10/26 $0.0498 +65.51% 94,532
06/10/26 $0.0301 -49.92% 372,442
05/10/26 $0.0601 -5.13% 28,815
02/10/26 $0.0634 +4.62% 64,514
01/10/26 $0.0606 +0.92% 20,870
  1. Stock Market
  2. Stocks
  3. LMED Stock